MICHELLE BAILEY: Open Payments
NPI 1952077521 · NORTH LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 18 payments from 10 companies in 2025. Trend: 2023 $579 · 2024 $594 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| Amgen Inc. | 3 | $71 |
| Lilly USA, LLC | 2 | $35 |
| Janssen Biotech, Inc. | 1 | $30 |
| Almirall LLC | 1 | $27 |
| GENZYME CORPORATION | 1 | $23 |
| Organon LLC | 2 | $22 |
| ABBVIE INC. | 1 | $22 |
| Botanix SB Inc | 1 | $17 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $14 |
Products named: COSENTYX, EVENITY, TREMFYA, Seysara, ENBREL, DUPIXENT, SKYRIZI, TALTZ.
Industry payments across UT — which companies pay providers there.
